57 related articles for article (PubMed ID: 1456270)
1. The genetic epidemiology of second primary breast cancer.
Bernstein JL; Thompson WD; Risch N; Holford TR
Am J Epidemiol; 1992 Oct; 136(8):937-48. PubMed ID: 1456270
[TBL] [Abstract][Full Text] [Related]
2. Risk of second primary malignancies in women with breast cancer: Results from the European prospective investigation into cancer and nutrition (EPIC).
Ricceri F; Fasanelli F; Giraudo MT; Sieri S; Tumino R; Mattiello A; Vagliano L; Masala G; Quirós JR; Travier N; Sánchez MJ; Larranaga N; Chirlaque MD; Ardanaz E; Tjonneland A; Olsen A; Overvad K; Chang-Claude J; Kaaks R; Boeing H; Clavel-Chapelon F; Kvaskoff M; Dossus L; Trichopoulou A; Benetou V; Adarakis G; Bueno-de-Mesquita HB; Peeters PH; Sund M; Andersson A; Borgquist S; Butt S; Weiderpass E; Skeie G; Khaw KT; Travis RC; Rinaldi S; Romieu I; Gunter M; Kadi M; Riboli E; Vineis P; Sacerdote C
Int J Cancer; 2015 Aug; 137(4):940-8. PubMed ID: 25650288
[TBL] [Abstract][Full Text] [Related]
3. Second primary cancers following breast cancer in the Japanese female population.
Tanaka H; Tsukuma H; Koyama H; Kinoshita Y; Kinoshita N; Oshima A
Jpn J Cancer Res; 2001 Jan; 92(1):1-8. PubMed ID: 11173537
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for developing multiple malignancies in patients with endometrial cancer.
Uccella S; Cha SS; Melton LJ; Bergstralh EJ; Boardman LA; Keeney GL; Podratz KC; Ciancio FF; Mariani A
Int J Gynecol Cancer; 2011 Jul; 21(5):896-901. PubMed ID: 21666488
[TBL] [Abstract][Full Text] [Related]
5. Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers.
Amin S; McBride RB; Kline JK; Mitchel EB; Lucas AL; Neugut AI; Frucht H
Cancer; 2012 Mar; 118(5):1244-51. PubMed ID: 21887676
[TBL] [Abstract][Full Text] [Related]
6. Family history of malignancies and risk of breast cancer: prospective data from the Shanghai women's health study.
Kilfoy BA; Zhang Y; Shu XO; Gao YT; Ji BT; Yang G; Li HL; Rothman N; Chow WH; Zheng W
Cancer Causes Control; 2008 Dec; 19(10):1139-45. PubMed ID: 18575953
[TBL] [Abstract][Full Text] [Related]
7. Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy.
Zhang W; Becciolini A; Biggeri A; Pacini P; Muirhead CR
Breast Cancer Res; 2011 Apr; 13(2):R38. PubMed ID: 21463502
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of developing contralateral breast cancer after first primary breast cancer treatment.
Avatefi M; HadavandSiri F; Nazari SSH; Akbari ME
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1927. PubMed ID: 37919558
[TBL] [Abstract][Full Text] [Related]
9. Infectious mononucleosis and risk of breast cancer in a prospective study of women.
Massa J; Hamdan A; Simon KC; Bertrand K; Wulf G; Tamimi RM; Ascherio A
Cancer Causes Control; 2012 Dec; 23(12):1893-8. PubMed ID: 23053791
[TBL] [Abstract][Full Text] [Related]
10. Evidence for familial clustering in breast cancer age of onset.
Von Holle A; O'Brien KM; Sandler DP; Weinberg CR
Int J Epidemiol; 2021 Mar; 50(1):97-104. PubMed ID: 33247915
[TBL] [Abstract][Full Text] [Related]
11. Bilateral Breast Cancer: Clinical Profile and Management.
Mishra A; Oberoi AS; Deo S; Sharma J; Gogia A; Sharma DN; Mathur S; Dhamija E
Indian J Surg Oncol; 2023 Sep; 14(3):651-658. PubMed ID: 37900630
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for contralateral breast cancer in postmenopausal breast cancer survivors in the NIH-AARP Diet and Health Study.
Ramin C; Mullooly M; Schonfeld SJ; Advani PG; Bodelon C; Gierach GL; Berrington de González A
Cancer Causes Control; 2021 Aug; 32(8):803-813. PubMed ID: 33877513
[TBL] [Abstract][Full Text] [Related]
13. Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer Who Are Genetic Carriers, Have a Strong Family History or Are just Young at Presentation.
Teoh V; Tasoulis MK; Gui G
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31935898
[TBL] [Abstract][Full Text] [Related]
14. Contralateral Breast Cancer Event Detection Using Nature Language Processing.
Zeng Z; Li X; Espino S; Roy A; Kitsch K; Clare S; Khan S; Luo Y
AMIA Annu Symp Proc; 2017; 2017():1885-1892. PubMed ID: 29854260
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study.
Reiner AS; Sisti J; John EM; Lynch CF; Brooks JD; Mellemkjær L; Boice JD; Knight JA; Concannon P; Capanu M; Tischkowitz M; Robson M; Liang X; Woods M; Conti DV; Duggan D; Shore R; Stram DO; Thomas DC; Malone KE; Bernstein L; ; Bernstein JL
J Clin Oncol; 2018 May; 36(15):1513-1520. PubMed ID: 29620998
[TBL] [Abstract][Full Text] [Related]
16. Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?
Miller ME; Muhsen S; Olcese C; Patil S; Morrow M; Van Zee KJ
Ann Surg Oncol; 2017 Oct; 24(10):2889-2897. PubMed ID: 28766208
[TBL] [Abstract][Full Text] [Related]
17. [Synchronous bilateral breast cancer: experiences in the Mohammed VI Cancer Treatment Center, CHU Ibn Rochd, Casablanca].
Khalil AI; Bendahhou K; Mestaghanmi H; Saile R; Benider A
Pan Afr Med J; 2016; 25():121. PubMed ID: 28292084
[TBL] [Abstract][Full Text] [Related]
18. Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.
Brooks JD; John EM; Mellemkjaer L; Lynch CF; Knight JA; Malone KE; Reiner AS; Bernstein L; Liang X; Shore RE; Stovall M; ; Bernstein JL
Cancer Med; 2016 Nov; 5(11):3282-3291. PubMed ID: 27700016
[TBL] [Abstract][Full Text] [Related]
19. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.
Reiner AS; John EM; Brooks JD; Lynch CF; Bernstein L; Mellemkjær L; Malone KE; Knight JA; Capanu M; Teraoka SN; Concannon P; Liang X; Figueiredo JC; Smith SA; Stovall M; Pike MC; Haile RW; Thomas DC; Begg CB; Bernstein JL
J Clin Oncol; 2013 Feb; 31(4):433-9. PubMed ID: 23269995
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.
Saltzman BS; Malone KE; McDougall JA; Daling JR; Li CI
Breast Cancer Res Treat; 2012 Oct; 135(3):849-55. PubMed ID: 22903686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
